Delivery Order SPE2DB22D1017-SPE2DB25FYPSB
- Not listed
- The Defense Logistics Agency awarded a $5,868.13 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5ML, a meningococcal conjugate vaccine. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work is to be performed at...
- The Defense Logistics Agency awarded a $61,593 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, was competitively awarded without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill the delivery order from its corporate office location. This contract...
- The Defense Logistics Agency awarded a delivery order valued at $154,601.82 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Menveo 1 vial conjugate meningococcal vaccine (groups A, C, Y, and W-135) in 0.5 mL formulations. This competitively awarded, firm fixed price contract is classified as a child order and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with completion expected by August 25, 2025. The delivery order carries...
- The Defense Logistics Agency awarded a delivery order valued at $14,403.86 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This competitively awarded, firm fixed-price delivery order was issued on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a standard transactional award under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,397.27 on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $31,521.00 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order was awarded on July 25, 2025, with an ultimate...
- The Defense Logistics Agency awarded a $5,553.09 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL, a meningococcal conjugate vaccine. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of August 5, 2025. The contract is being performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL, a meningococcal conjugate vaccine, with a ceiling value of $1,613.15. This firm fixed-price delivery order, which is set to be completed by August 8, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $85,622.94 delivery order to AmerisourceBergen Drug Corp for MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine product, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a $61,593.00 delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial A-C-Y-W-135-DIP (0.5ML), a meningococcal vaccine product. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and was competitively awarded without any set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPSBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,517.62 to AmerisourceBergen Drug Corp for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. The order is scheduled for completion by September 3, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider supporting federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio encompasses delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific vaccine delivery supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through AmerisourceBergen's comprehensive global pharmaceutical supply vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 9/2/25 |